See more : Leoch International Technology Limited (LCHIF) Income Statement Analysis – Financial Results
Complete financial analysis of Afya Limited (AFYA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Afya Limited, a leading company in the Education & Training Services industry within the Consumer Defensive sector.
- My Rewards International Limited (MRI.AX) Income Statement Analysis – Financial Results
- Pop Mart International Group Limited (9992.HK) Income Statement Analysis – Financial Results
- B90 Holdings PLC (B90.L) Income Statement Analysis – Financial Results
- Okins Electronics Co., Ltd. (080580.KQ) Income Statement Analysis – Financial Results
- Chunghwa Precision Test Tech. Co., Ltd. (6510.TWO) Income Statement Analysis – Financial Results
Afya Limited (AFYA)
About Afya Limited
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. As of December 31, 2021, it operated a network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units and five approved units; and a network of 2,731 medical school seats that consisted of 2,481 operating seats and 278 approved seats. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|---|
Revenue | 2.88B | 2.33B | 1.72B | 1.20B | 750.63M | 333.94M | 216.01M |
Cost of Revenue | 1.11B | 859.55M | 652.30M | 434.65M | 308.85M | 168.05M | 124.07M |
Gross Profit | 1.77B | 1.47B | 1.07B | 766.54M | 441.78M | 165.88M | 91.94M |
Gross Profit Ratio | 61.41% | 63.09% | 62.06% | 63.81% | 58.85% | 49.68% | 42.56% |
Research & Development | 21.50M | 9.44M | 625.00K | 32.00K | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.01B | 798.15M | 622.62M | 402.86M | 239.12M | 70.03M | 45.36M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.01B | 798.15M | 622.62M | 402.86M | 239.12M | 70.03M | 45.36M |
Other Expenses | -37.15M | 7.43M | 6.87M | 347.00K | 4.21M | -599.00K | -2.76M |
Operating Expenses | 999.04M | 805.58M | 629.48M | 403.20M | 243.33M | 69.44M | 42.60M |
Cost & Expenses | 2.11B | 1.67B | 1.28B | 837.86M | 552.18M | 237.49M | 166.67M |
Interest Income | 107.12M | 27.20M | 23.04M | 62.29M | 9.68M | 4.36M | 3.17M |
Interest Expense | 386.30M | 288.65M | 175.65M | 98.27M | 55.47M | 2.40M | 1.04M |
Depreciation & Amortization | 289.51M | 211.94M | 159.57M | 109.50M | 74.60M | 9.62M | 4.18M |
EBITDA | 1.11B | 856.35M | 541.80M | 433.11M | 257.75M | 104.35M | 52.67M |
EBITDA Ratio | 38.44% | 36.77% | 34.05% | 45.13% | 37.04% | 32.04% | 25.01% |
Operating Income | 767.06M | 664.10M | 440.90M | 363.34M | 205.25M | 96.45M | 49.34M |
Operating Income Ratio | 26.67% | 28.51% | 25.64% | 30.25% | 27.34% | 28.88% | 22.84% |
Total Other Income/Expenses | -337.48M | -235.67M | -167.43M | -28.28M | -18.31M | 2.27M | 1.64M |
Income Before Tax | 429.58M | 428.43M | 273.46M | 335.05M | 186.94M | 98.72M | 50.98M |
Income Before Tax Ratio | 14.94% | 18.40% | 15.90% | 27.89% | 24.90% | 29.56% | 23.60% |
Income Tax Expense | 24.17M | 35.68M | 31.18M | 27.07M | 14.18M | 3.99M | 2.50M |
Net Income | 386.32M | 373.57M | 223.33M | 292.08M | 153.92M | 86.35M | 45.39M |
Net Income Ratio | 13.43% | 16.04% | 12.99% | 24.32% | 20.50% | 25.86% | 21.01% |
EPS | 4.27 | 4.15 | 2.39 | 3.15 | 2.03 | 0.98 | 0.52 |
EPS Diluted | 4.27 | 4.15 | 2.37 | 3.12 | 2.02 | 0.98 | 0.52 |
Weighted Avg Shares Out | 90.47M | 89.94M | 93.29M | 92.68M | 75.97M | 87.68M | 87.68M |
Weighted Avg Shares Out (Dil) | 90.54M | 89.94M | 94.10M | 93.64M | 76.19M | 87.68M | 87.68M |
Wall Street Analysts Think Afya (AFYA) Could Surge 32.79%: Read This Before Placing a Bet
Should Value Investors Buy Afya (AFYA) Stock?
AFYA vs. BFAM: Which Stock Is the Better Value Option?
Afya Limited Announces Results of Annual General Meeting Held on June 5, 2024
Afya Limited (the "Company") Notice of Annual General Meeting of the Company
Afya Limited (AFYA) Q1 2024 Earnings Call Transcript
Afya (AFYA) Tops Q1 Earnings and Revenue Estimates
Afya Limited Announces First-Quarter 2024 Financial Results
Afya Limited Announces Entering Into a Share Purchase Agreement for the Acquisition of Unidompedro and Faculdade Dom Luiz
AFYA vs. LOPE: Which Stock Should Value Investors Buy Now?
Source: https://incomestatements.info
Category: Stock Reports